Our Latest Published Articles
Drug developer Novartis spent just over $1.6 million in the second quarter lobbying the U.S. government on prescription drug issues and other legislation, according to a recent disclosure form.
The spending marks an 11 percent reduction from just over $1.8 million spent in the …..
Go to source